GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (STU:9OM1) » Definitions » Shiller PE Ratio

EXMceuticals (STU:9OM1) Shiller PE Ratio : (As of May. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is EXMceuticals Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


EXMceuticals Shiller PE Ratio Historical Data

The historical data trend for EXMceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Shiller PE Ratio Chart

EXMceuticals Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

EXMceuticals Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of EXMceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, EXMceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EXMceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EXMceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where EXMceuticals's Shiller PE Ratio falls into.



EXMceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

EXMceuticals's E10 for the quarter that ended in Mar. 2021 is calculated as:

For example, EXMceuticals's adjusted earnings per share data for the three months ended in Mar. 2021 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2021 (Change)*Current CPI (Mar. 2021)
=-0.02/110.2976*110.2976
=-0.020

Current CPI (Mar. 2021) = 110.2976.

EXMceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201106 -0.107 94.654 -0.125
201109 -0.002 95.286 -0.002
201112 -0.009 94.970 -0.010
201203 -0.004 96.155 -0.005
201206 -0.047 96.076 -0.054
201209 -0.005 96.392 -0.006
201212 -0.005 95.760 -0.006
201303 -0.005 97.103 -0.006
201306 0.000 97.182 0.000
201309 0.000 97.419 0.000
201312 0.000 96.945 0.000
201403 -0.007 98.604 -0.008
201406 -0.014 99.473 -0.016
201409 -0.003 99.394 -0.003
201412 -0.007 98.367 -0.008
201503 -0.007 99.789 -0.008
201506 -0.029 100.500 -0.032
201509 -0.002 100.421 -0.002
201512 -0.007 99.947 -0.008
201603 -0.007 101.054 -0.008
201606 -0.014 102.002 -0.015
201609 -0.001 101.765 -0.001
201612 -0.001 101.449 -0.001
201703 -0.002 102.634 -0.002
201706 0.000 103.029 0.000
201709 -0.001 103.345 -0.001
201712 -0.007 103.345 -0.007
201803 -0.006 105.004 -0.006
201806 0.000 105.557 0.000
201809 -0.012 105.636 -0.013
201812 -0.002 105.399 -0.002
201903 -0.099 106.979 -0.102
201906 -0.047 107.690 -0.048
201909 -0.027 107.611 -0.028
201912 -0.027 107.769 -0.028
202003 -0.045 107.927 -0.046
202006 -0.066 108.401 -0.067
202009 -0.019 108.164 -0.019
202012 -0.013 108.559 -0.013
202103 -0.020 110.298 -0.020

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


EXMceuticals  (STU:9OM1) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


EXMceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of EXMceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EXMceuticals (STU:9OM1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9
EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (STU:9OM1) Headlines

No Headlines